p73 in apoptosis

被引:60
作者
Stiewe, T [1 ]
Pützer, BM [1 ]
机构
[1] Univ Essen Gesamthsch, Sch Med, Inst Mol Biol, Ctr Canc Res & Canc Therapy, D-45122 Essen, Germany
关键词
apoptosis; p73; tumour suppressor;
D O I
10.1023/A:1012433522902
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The TP53 tumour-suppressor gene belongs to a family that includes the two recently identified homologues TP63 and TP73. Overexpression of p73 can activate typical p53-responsive genes and induce apoptosis like p53. In addition, activation of p73 has been implicated in apoptotic cell death induced by aberrant cell proliferation and some forms of DNA-damage. These data together with the localization of TP73 on chromosome 1p36, a region frequently deleted in a variety of human cancers, led to the hypothesis that p73 has tumour suppressor activity just like p53. However, despite its proapoptotic activity in vitro, the lack of tumour-formation in p73 knock-out mice and primary human tumour data demonstrating overexpression of wild-type p73 currently argue against p73 being a classical tumour suppressor. Interestingly, in contrast to TP53, TP73 gives rise to a complex pattern of pro- and antiapoptotic p73 isoforms generated by differential splicing and alternative promoter usage. Therefore further insight into the function and regulation of these structurally and functionally diverse p73 proteins is needed to elucidate the role of TP73 for apoptosis and human tumorigenesis.
引用
收藏
页码:447 / 452
页数:6
相关论文
共 67 条
[1]   Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage [J].
Agami, R ;
Bernards, R .
CELL, 2000, 102 (01) :55-66
[2]   Recruitment of p300/CBP in p53-dependent signal pathways [J].
Avantaggiati, ML ;
Ogryzko, V ;
Gardner, K ;
Giordano, A ;
Levine, AS ;
Kelly, K .
CELL, 1997, 89 (07) :1175-1184
[3]   Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation [J].
Baskaran, R ;
Wood, LD ;
Whitaker, LL ;
Canman, CE ;
Morgan, SE ;
Xu, Y ;
Barlow, C ;
Baltimore, D ;
WynshawBoris, A ;
Kastan, MB ;
Wang, JYJ .
NATURE, 1997, 387 (6632) :516-519
[4]   p14ARF links the tumour suppressors RB and p53 [J].
Bates, S ;
Phillips, AC ;
Clark, PA ;
Stott, F ;
Peters, G ;
Ludwig, RL ;
Vousden, KH .
NATURE, 1998, 395 (6698) :124-125
[5]  
Brooks LA, 2000, CANCER RES, V60, P6875
[6]   Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma [J].
Casciano, I ;
Ponzoni, M ;
Lo Cunsolo, C ;
Tonini, GP ;
Romani, M .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (05) :391-393
[7]   The p53 family: same response, different signals? [J].
Chen, XB .
MOLECULAR MEDICINE TODAY, 1999, 5 (09) :387-392
[8]   p73 is transcriptionally regulated by DNA damage, p53, and p73 [J].
Chen, XB ;
Zheng, YM ;
Zhu, JH ;
Jiang, JY ;
Wang, J .
ONCOGENE, 2001, 20 (06) :769-774
[9]   Additional complexity in p73:: induction by mitogens in lymphoid cells and identification of two new splicing variants ε and ζ [J].
De Laurenzi, V ;
Catani, MV ;
Terrinoni, A ;
Corazzari, M ;
Melino, G ;
Costanzo, A ;
Levrero, M ;
Knight, RA .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (05) :389-390
[10]   Two new p73 splice variants, γ and δ, with different transcriptional activity [J].
De Laurenzi, V ;
Costanzo, A ;
Barcaroli, D ;
Terrinoni, A ;
Falco, M ;
Annicchiarico-Petruzzeli, M ;
Levrero, M ;
Melino, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1763-1768